## Abstract Hepatitis C virus (HCV), a positive stranded RNA virus, is the main causative agent of post‐transfusion and sporadic non‐A non‐B hepatitis worldwide. Paired samples of plasma and peripheral blood mononuclear cells (PBMC) from 11 patients with chronic hepatitis C treated with α‐interfero
Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha
✍ Scribed by M. Basaras; B. de las Heras; M. García Bengoechea; L. Gallego; E. Arrese; R. Cisterna
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 316 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We tested serial serum samples for hepatitis C virus RNA from patients undergoing treatment for chronic hepatitis C with interferon-a using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 20 patients with chronic hepatitis who had serum antibody
Although the liver is the main target for hepatitis C virus (HCV) infection, HCV RNA of positive and negative polarity has also been detected in peripheral blood mononuclear cells (PBMCs) by polymerase chain reaction. However, no data have been published on the relationship between the number of HCV
We quantified serum hepatitis C virus RNA titers and determined hepatltis C virus subtypes in chronic hepatitis C patients treated with interferon$ to investigate relationships among serum ALT response, serum hepatitis C virus titer and hepatitis C virus subtype. Of 146 chronic hepatitis C patients
Hepatitis C virus (HCV) can infect peripheral blood mately 10 kb. 2 Acute posttransfusion hepatitis C mononuclear cells (PBMC) of patients with chronic HCV (PTHC) is followed by chronic hepatitis in about 50% infection. No data are available on PBMC testing for of the cases. Chronic hepatitis may al
Peripheral blood mononuclear cell proliferative responses in uitro to recombinant yeast or Escherichia coli hepatitis C virus fusion proteins were evaluated in 20 patients with chronic hepatitis C who were reactive for antibody to hepatitis C virus (on enzyme immunoassay, version 2.0, and a four-ant